{"nct_id":"NCT01868022","title":"Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling","status":"COMPLETED","status_verified_date":"2019-08","start_date":"2013-10-09","start_date_type":"ACTUAL","primary_completion_date":"2017-10-24","primary_completion_date_type":"ACTUAL","completion_date":"2017-10-24","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}